China Pharma (NYSE:CPHI) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI) in a research report sent to investors on Thursday morning. The brokerage issued a hold rating on the stock.

China Pharma Stock Performance

Shares of CPHI stock opened at $0.23 on Thursday. The stock has a 50-day simple moving average of $0.22 and a 200 day simple moving average of $0.21. The company has a quick ratio of 0.26, a current ratio of 0.79 and a debt-to-equity ratio of 0.22. China Pharma has a fifty-two week low of $0.13 and a fifty-two week high of $0.44.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.